Clinic
Alegent Health Bergan Mercy Health System
Alegent Health Bergan Mercy Health System was paid $13.02M by Medicaid between Jan 2018 and Dec 2024, across 81 billing codes. Its largest line is 99284, emergency room visit (serious) — 36% of everything it billed.
33Billing provider infoALEGENT HEALTH BERGAN MERCY HEALTH SYSTEM
COUNCIL BLUFFS, IA 51503
COUNCIL BLUFFS, IA 51503
33aNPI1265517759assigned 10/25/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$13.02M
24GClaims212,709
24DCodes billed81
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Iowa
Rank by total paid#1 of 25
Median peer was paid$194K
This provider vs. median67×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,974 | $2.56M | |
| 2019 | 32,105 | $2.10M | |
| 2020 | 22,827 | $1.38M | |
| 2021 | 31,290 | $1.87M | |
| 2022 | 36,845 | $1.95M | |
| 2023 | 32,133 | $1.73M | |
| 2024incomplete | 24,535 | $1.45M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 36% | 22,300 | 20,583 | $4.67M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 33% | 29,721 | 28,059 | $4.24M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10% | 4,262 | 3,821 | $1.35M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.5% | 8,482 | 7,736 | $853K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 4.0% | 1,939 | 298 | $523K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 2,375 | 2,285 | $202K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 1,977 | 1,839 | $191K |
| 97597 | 1.3% | 1,650 | 680 | $165K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,864 | 3,487 | $128K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 646 | 597 | $117K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,535 | 1,430 | $99K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,846 | 1,709 | $99K |
69 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,290 | $94K |
| 80050 | General health panel | <1% | 1,728 | $57K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 791 | $52K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 252 | $51K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 12 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 214 | $24K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,021 | $13K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 166 | $10K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 277 | $7K |
| 80053 | Comprehensive metabolic panel | <1% | 22,136 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 54 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,507 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 25,897 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 166 | $3K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 3,880 | $3K |
| G0378 | Hospital observation service, per hour | <1% | 253 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,063 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,668 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,738 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 155 | $766.66 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 15 | $746.24 |
| 81001 | <1% | 3,444 | $728.73 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,192 | $494.41 |
| J2704 | Injection, propofol, 10 mg | <1% | 951 | $490.20 |
| 83690 | <1% | 4,884 | $462.62 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 13 | $213.81 |
| 84484 | <1% | 4,755 | $134.22 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,082 | $91.97 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 108 | $91.03 |
| 87480 | <1% | 15 | $90.08 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,133 | $61.69 |
| 80061 | Lipid panel | <1% | 15 | $58.12 |
| J3490 | Unclassified drugs | <1% | 3,576 | $54.10 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,280 | $53.04 |
| 83880 | <1% | 138 | $48.23 | |
| 82077 | <1% | 440 | $47.86 | |
| 87510 | <1% | 15 | $45.04 | |
| 87660 | <1% | 15 | $45.04 | |
| 84703 | <1% | 1,925 | $27.03 | |
| 81003 | <1% | 2,223 | $22.86 | |
| 85730 | <1% | 893 | $13.62 | |
| 85610 | <1% | 1,093 | $13.47 | |
| 81025 | <1% | 1,166 | $12.76 | |
| 83605 | <1% | 736 | $9.78 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,304 | $8.20 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 733 | $0.04 |
| 85379 | 0% | 72 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 40 | $0.00 |
| 87081 | 0% | 148 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 28 | $0.00 |
| 83735 | 0% | 198 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 14 | $0.00 |
| 87147 | 0% | 26 | $0.00 | |
| 82550 | 0% | 63 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 14 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 29 | $0.00 |
| 82553 | 0% | 63 | $0.00 | |
| 94760 | 0% | 23 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 14 | $0.00 |
| 86140 | 0% | 16 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 15 | $0.00 |
| 80143 | 0% | 79 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 317 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 278 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 129 | $0.00 |
| 80179 | 0% | 78 | $0.00 | |
| 87420 | 0% | 28 | $0.00 | |
| 74018 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGILES, PAUL (SYS DIRECTOR, GOVERNMENT ENROLLMENT)